Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
28
NCT00489294
Safety Study of Syntropin (Human Growth Hormone) for the Treatment of Growth Hormone Deficiency
Phase: Phase 1
Role: Lead Sponsor
Start: Aug 31, 2004
Completion: Jun 30, 2005
NCT00916292
Safety Study of Topical Human FGF-1 for Wound Healing
Start: Nov 30, 2012
Completion: Sep 30, 2013